CRVS Annual Net Income
-$27.03 M
+$14.28 M+34.57%
31 December 2023
Summary:
As of January 21, 2025, CRVS annual net profit is -$27.03 million, with the most recent change of +$14.28 million (+34.57%) on December 31, 2023. During the last 3 years, it has fallen by -$21.03 million (-350.86%). CRVS annual net income is now -350.86% below its all-time high of -$6.00 million, reached on December 31, 2020.CRVS Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRVS Quarterly Net Income
-$40.22 M
-$35.95 M-843.62%
30 September 2024
Summary:
As of January 21, 2025, CRVS quarterly net profit is -$40.22 million, with the most recent change of -$35.95 million (-843.62%) on September 30, 2024. Over the past year, it has dropped by -$34.22 million (-570.28%). CRVS quarterly net income is now -247.06% below its all-time high of $27.35 million, reached on December 31, 2020.CRVS Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRVS TTM Net Income
-$56.83 M
-$34.22 M-151.30%
30 September 2024
Summary:
As of January 21, 2025, CRVS TTM net profit is -$56.83 million, with the most recent change of -$34.22 million (-151.30%) on September 30, 2024. Over the past year, it has dropped by -$26.64 million (-88.24%). CRVS TTM net income is now -2870.88% below its all-time high of -$1.91 million, reached on March 31, 2015.CRVS TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRVS Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.6% | -570.3% | -88.2% |
| 3 y3 years | -350.9% | -309.7% | -37.6% |
| 5 y5 years | +42.4% | -309.7% | -37.6% |
CRVS Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +37.5% | -843.6% | at low | -151.3% | at low |
| 5 y | 5-year | -350.9% | +42.1% | -247.1% | at low | -1124.8% | at low |
| alltime | all time | -350.9% | +51.4% | -247.1% | at low | -2870.9% | at low |
Corvus Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$40.22 M(+843.6%) | -$56.83 M(+151.3%) |
| June 2024 | - | -$4.26 M(-25.2%) | -$22.62 M(-9.0%) |
| Mar 2024 | - | -$5.70 M(-14.3%) | -$24.86 M(-8.0%) |
| Dec 2023 | -$27.03 M(-34.6%) | -$6.65 M(+10.9%) | -$27.03 M(-10.5%) |
| Sept 2023 | - | -$6.00 M(-7.7%) | -$30.19 M(-22.6%) |
| June 2023 | - | -$6.50 M(-17.4%) | -$39.02 M(-4.5%) |
| Mar 2023 | - | -$7.87 M(-19.8%) | -$40.88 M(-1.0%) |
| Dec 2022 | -$41.31 M(-4.5%) | -$9.82 M(-33.8%) | -$41.31 M(+1.4%) |
| Sept 2022 | - | -$14.83 M(+77.3%) | -$40.73 M(+11.4%) |
| June 2022 | - | -$8.36 M(+0.8%) | -$36.57 M(-8.5%) |
| Mar 2022 | - | -$8.30 M(-10.2%) | -$39.96 M(-7.6%) |
| Dec 2021 | -$43.24 M(+621.3%) | -$9.24 M(-13.5%) | -$43.24 M(+549.5%) |
| Sept 2021 | - | -$10.67 M(-9.2%) | -$6.66 M(+15.2%) |
| June 2021 | - | -$11.75 M(+1.5%) | -$5.78 M(+24.6%) |
| Mar 2021 | - | -$11.58 M(-142.3%) | -$4.64 M(-22.6%) |
| Dec 2020 | -$6.00 M(-87.2%) | $27.35 M(-379.2%) | -$6.00 M(-86.5%) |
| Sept 2020 | - | -$9.80 M(-7.7%) | -$44.39 M(-2.6%) |
| June 2020 | - | -$10.61 M(-18.0%) | -$45.60 M(-4.9%) |
| Mar 2020 | - | -$12.94 M(+17.1%) | -$47.96 M(+2.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$46.67 M(-0.6%) | -$11.05 M(+0.4%) | -$46.67 M(+1.2%) |
| Sept 2019 | - | -$11.00 M(-15.2%) | -$46.13 M(+1.1%) |
| June 2019 | - | -$12.98 M(+11.5%) | -$45.63 M(+3.0%) |
| Mar 2019 | - | -$11.64 M(+10.8%) | -$44.28 M(-5.7%) |
| Dec 2018 | -$46.94 M(-15.7%) | -$10.51 M(+0.1%) | -$46.94 M(-2.9%) |
| Sept 2018 | - | -$10.50 M(-9.7%) | -$48.36 M(-4.4%) |
| June 2018 | - | -$11.63 M(-18.7%) | -$50.58 M(-6.2%) |
| Mar 2018 | - | -$14.30 M(+19.9%) | -$53.93 M(-3.1%) |
| Dec 2017 | -$55.66 M(+53.0%) | -$11.93 M(-6.2%) | -$55.66 M(+1.5%) |
| Sept 2017 | - | -$12.72 M(-15.1%) | -$54.82 M(+4.6%) |
| June 2017 | - | -$14.98 M(-6.6%) | -$52.40 M(+13.8%) |
| Mar 2017 | - | -$16.04 M(+44.7%) | -$46.06 M(+26.6%) |
| Dec 2016 | -$36.38 M(+16.1%) | -$11.09 M(+7.7%) | -$36.38 M(+16.1%) |
| Sept 2016 | - | -$10.30 M(+19.1%) | -$31.33 M(+29.6%) |
| June 2016 | - | -$8.64 M(+36.2%) | -$24.18 M(-32.4%) |
| Mar 2016 | - | -$6.35 M(+5.1%) | -$35.77 M(+14.2%) |
| Dec 2015 | -$31.34 M | -$6.04 M(+91.7%) | -$31.34 M(+23.9%) |
| Sept 2015 | - | -$3.15 M(-84.4%) | -$25.30 M(+14.2%) |
| June 2015 | - | -$20.23 M(+957.6%) | -$22.14 M(+1057.6%) |
| Mar 2015 | - | -$1.91 M | -$1.91 M |
FAQ
- What is Corvus Pharmaceuticals annual net profit?
- What is the all time high annual net income for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals annual net income year-on-year change?
- What is Corvus Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals quarterly net income year-on-year change?
- What is Corvus Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals TTM net income year-on-year change?
What is Corvus Pharmaceuticals annual net profit?
The current annual net income of CRVS is -$27.03 M
What is the all time high annual net income for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high annual net profit is -$6.00 M
What is Corvus Pharmaceuticals annual net income year-on-year change?
Over the past year, CRVS annual net profit has changed by +$14.28 M (+34.57%)
What is Corvus Pharmaceuticals quarterly net profit?
The current quarterly net income of CRVS is -$40.22 M
What is the all time high quarterly net income for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high quarterly net profit is $27.35 M
What is Corvus Pharmaceuticals quarterly net income year-on-year change?
Over the past year, CRVS quarterly net profit has changed by -$34.22 M (-570.28%)
What is Corvus Pharmaceuticals TTM net profit?
The current TTM net income of CRVS is -$56.83 M
What is the all time high TTM net income for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high TTM net profit is -$1.91 M
What is Corvus Pharmaceuticals TTM net income year-on-year change?
Over the past year, CRVS TTM net profit has changed by -$26.64 M (-88.24%)